These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


108 related items for PubMed ID: 17904241

  • 1. Increased insulin resistance and hyperinsulinemia in patients with type 2 diabetes and chronic hepatitis C.
    Oliveira BR, Magalhães O, Furlanetto TW, Bertoluci MC.
    Diabetes Res Clin Pract; 2008 Feb; 79(2):e11-2. PubMed ID: 17904241
    [No Abstract] [Full Text] [Related]

  • 2. Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment.
    Harrison SA.
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):864-76. PubMed ID: 18585970
    [Abstract] [Full Text] [Related]

  • 3. Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus.
    Donadon V, Balbi M, Zanette G.
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):465-7. PubMed ID: 19817667
    [No Abstract] [Full Text] [Related]

  • 4. [Natural history of insulin resistance and hyperinsulinism in non-insulin-dependent diabetic patients].
    Vague P, Raccah D.
    Journ Annu Diabetol Hotel Dieu; 1990 Oct; ():201-9. PubMed ID: 2195206
    [No Abstract] [Full Text] [Related]

  • 5. Insulin sensitivity and hypertension.
    Ferrannini E, Haffner SM, Stern MP.
    J Hypertens Suppl; 1990 Dec; 8(7):S169-74. PubMed ID: 2095386
    [No Abstract] [Full Text] [Related]

  • 6. The clinical relevance of pancreatic B-cell hyperplasia, hyperinsulinism and insulin insensitivity in non-insulin dependent diabetes mellitus.
    Mahler RJ.
    Horm Metab Res; 1987 Nov; 19(11):565-8. PubMed ID: 3323021
    [No Abstract] [Full Text] [Related]

  • 7. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
    Imazeki F, Yokosuka O, Fukai K, Kanda T, Kojima H, Saisho H.
    Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
    [Abstract] [Full Text] [Related]

  • 8. Specific phenotype associated with diabetes mellitus secondary to chronic hepatitis C infection.
    Poussier A, Lebouvier M, Penfornis A, Di Martino V, Buffier P, Verges B, Hillon P, Petit JM.
    Diabet Med; 2008 Oct; 25(10):1237-40. PubMed ID: 19046205
    [Abstract] [Full Text] [Related]

  • 9. Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C.
    Kawaguchi Y, Mizuta T, Oza N, Takahashi H, Ario K, Yoshimura T, Eguchi Y, Ozaki I, Hisatomi A, Fujimoto K.
    Liver Int; 2009 Jul; 29(6):871-7. PubMed ID: 19302179
    [Abstract] [Full Text] [Related]

  • 10. The many faces of hepatitis C: liver disease and type 2 diabetes.
    Milner KL, Chisholm D, George J.
    Hepatology; 2009 Sep; 50(3):668-70. PubMed ID: 19670421
    [No Abstract] [Full Text] [Related]

  • 11. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
    Ruge T, Lockton JA, Renstrom F, Lystig T, Sukonina V, Svensson MK, Eriksson JW.
    Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
    [Abstract] [Full Text] [Related]

  • 12. [Arterial hypertension and diabetes mellitus].
    Arq Bras Cardiol; 1992 Sep; 59(3):231-7. PubMed ID: 1341177
    [No Abstract] [Full Text] [Related]

  • 13. Hepatitis C and diabetes: the inevitable coincidence?
    Lonardo A, Adinolfi LE, Petta S, Craxì A, Loria P.
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243
    [Abstract] [Full Text] [Related]

  • 14. [Hyperinsulinemia as a key factor in the development of many metabolic disorders].
    Lepsanović L, Lepsanović L, Ivković-Lazar T, Babić L, Derić M, Stokić E, Curić N.
    Med Pregl; 1997 Apr; 50(11-12):469-72. PubMed ID: 9471505
    [Abstract] [Full Text] [Related]

  • 15. Revisit of oral glucose tolerance test: a must for diagnosis of type 2 diabetes in patients with chronic hepatitis C.
    Heish MY, Dai CY, Huang JF, Lee LP, Hou NJ, Chuang WL, Yu ML.
    Am J Gastroenterol; 2008 Feb; 103(2):487-8; author reply 488. PubMed ID: 18289212
    [No Abstract] [Full Text] [Related]

  • 16. Impact of host insulin resistance on fibrosis and response to interferon in chronic hepatitis C.
    Moţa M, Popa S, Mota E, Diaconescu I, Gheorghiţoiu I, Panduru M.
    Rom J Intern Med; 2008 Feb; 46(2):105-12. PubMed ID: 19284081
    [Abstract] [Full Text] [Related]

  • 17. Insulin and hypertension: a causal relationship?
    Bhanot S, McNeill JH.
    Cardiovasc Res; 1996 Feb; 31(2):212-21. PubMed ID: 8730395
    [No Abstract] [Full Text] [Related]

  • 18. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S, Cammà C, Di Marco V, Alessi N, Cabibi D, Caldarella R, Licata A, Massenti F, Tarantino G, Marchesini G, Craxì A.
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [Abstract] [Full Text] [Related]

  • 19. Modification of diabetic retinopathy presentation by underlying hepatitis C infection.
    Arora S, Rehman SU.
    Eye (Lond); 2006 Apr; 20(4):496-7. PubMed ID: 15877095
    [No Abstract] [Full Text] [Related]

  • 20. Hepatitis C is associated with type 2 diabetes mellitus in HIV-infected persons without traditional risk factors.
    Jain MK, Aragaki C, Fischbach L, Gibson S, Arora R, May L, Vardhineni K, Lee WM.
    HIV Med; 2007 Nov; 8(8):491-7. PubMed ID: 17944681
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.